Signaling Pathways - Ubiquitin E3 Ligases - IMPDH - EZH2 - MK2
清除全部
- C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B5549 PF-3644022Target: MK2Summary: MK2抑制剂
- B4678 CPI-1691 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- B1112 MerimepodibTarget: IMPDHSummary: IMPDH(肌苷单磷酸脱氢酶)的新型非竞争性抑制剂
- B1583 UNC19992 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂
- A3449 GSK3431 CitationTarget: EZH2Summary: EZH2抑制剂
- A3446 GSK1265 CitationTarget: EZH2Summary: EZH2抑制剂
- A4216 Thalidomide中文名: 沙利度胺Target: Ubiquitin E3 LigasesSummary: 免疫调节剂,镇静药,血管生成抑制剂